Aprepitant is a selective high-affinity antagonist at human substance P neurokinin 1 (NK1) receptors.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Aprepitant is the active ingredient of these drugs:
Ecuador
Germany
South Africa
Austria
United States
Austria Brazil Canada Cyprus Ecuador
South Africa
South Africa
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):